Lab901, Seegene Strike Distribution, Co-marketing Agreement | GenomeWeb
NEW YORK (GenomeWeb News) – The Korean PCR diagnostics company Seegene will distribute Lab901’s ScreenTape system in the Korean market, Lab901 said Monday.
Under the agreement, the two companies will co-market both the ScreenTape system and Seegene’s Seeplex products in the global market, the company said.
The Seeplex products are multiplex PCR-based tests designed to detect multiple pathogens, including sexually transmitted diseases, respiratory viruses, sepsis, human papillomavirus, and pneumonia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.